EYE — Nova Eye Medical Balance Sheet
0.000.00%
Last trade - 00:00- AU$36.94m
- AU$34.90m
- AU$29.27m
- 48
- 58
- 48
- 51
Annual balance sheet for Nova Eye Medical, fiscal year end - June 30th, AUD millions except per share, conversion factor applied.
2021 June 30th | 2022 June 30th | 2023 June 30th | 2024 June 30th | 2025 June 30th | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Cash and Short Term Investments | 17.8 | 8 | 7.42 | 6.15 | 5.05 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 5.43 | 3.77 | 3.1 | 4.08 | 4.18 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 26.3 | 15.6 | 14.6 | 14.7 | 12.3 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 3.51 | 2.94 | 2.36 | 3.9 | 3.36 |
| Net Intangible Assets | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 42 | 36.6 | 30.4 | 29.9 | 26.5 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 4.69 | 3.86 | 6.27 | 5.68 | 5.15 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 6.66 | 6.23 | 7.17 | 8.55 | 7.54 |
| Common Stock | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | 35.3 | 30.4 | 23.2 | 21.3 | 19 |
| Total Liabilities & Shareholders' Equity | 42 | 36.6 | 30.4 | 29.9 | 26.5 |
| Total Common Shares Outstanding |